FORMULIERUNGEN VON COPANLISIB

European patent · EP3678644 · Deleted

Register entry

Publication number
EP3678644
Application number
EP18762107
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 6, 2018
Published
Jul 15, 2020
Granted
May 3, 2023
Deleted
Apr 25, 2025
Reason
Annual fee unpaid
IPC classes
A61K 9/19 (2006.01)
A61K 9/08 (2006.01)
A61K 47/02 (2006.01)
A61K 47/26 (2006.01)
Priority
EP 17190117 08.09.2017
EP 17207771 15.12.2017
PCT application
PCT/EP2018/073965 06.09.2018
PCT publication
WO2019/048527 14.03.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 25, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.04.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.04.2025

  2. Mar 13, 2024

    Change

    Published in Swissreg on 13.03.2024

  3. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  4. May 3, 2023

    Granted

    Published in Swissreg on 03.05.2023

Parties

Holder

Bayer Consumer Care AG

Peter Merian-Strasse 84, 4052 Basel

Bayer Pharma Aktiengesellschaft

Müllerstrasse 178, 13353 Berlin, DE

Inventor

FREUNDLIEB, Julia

44229 Dortmund, DE

JACOBS, Tia

42115 Wuppertal, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.